"Neurotoxicity Syndromes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.
Descriptor ID |
D020258
|
MeSH Number(s) |
C10.720 C25.723.705
|
Concept/Terms |
Neurotoxicity Syndromes- Neurotoxicity Syndromes
- Neurotoxicity Syndrome
- Syndrome, Neurotoxicity
- Syndromes, Neurotoxicity
- Neurotoxin Disorders
- Neurotoxin Disorder
- Neurotoxic Disorders
- Neurotoxic Disorder
- Neurotoxin Diseases
- Neurotoxin Disease
- Poisoning, Nervous System
- Nervous System Poisonings
- Poisonings, Nervous System
- Nervous System Poisoning
Encephalopathy, Toxic- Encephalopathy, Toxic
- Encephalopathies, Toxic
- Toxic Encephalopathies
- Toxic Encephalopathy
Toxic Encephalitis- Toxic Encephalitis
- Encephalitides, Toxic
- Encephalitis, Toxic
- Toxic Encephalitides
|
Below are MeSH descriptors whose meaning is more general than "Neurotoxicity Syndromes".
Below are MeSH descriptors whose meaning is more specific than "Neurotoxicity Syndromes".
This graph shows the total number of publications written about "Neurotoxicity Syndromes" by people in this website by year, and whether "Neurotoxicity Syndromes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2011 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurotoxicity Syndromes" by people in Profiles.
-
Schneider JS. Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent? Environ Health Perspect. 2023 08; 131(8):85002.
-
Banerjee R, Shah N, Dicker AP. Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clin Cancer Inform. 2021 06; 5:668-678.
-
Mack AH, Schofield HL. Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation. Psychosomatics. 2020 Nov-Dec; 61(6):859-860.
-
Balderia PG, Chandorkar A, Kim Y, Patnaik S, Sloan J, Newman GC. Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient With Kidney Transplant. J Patient Saf. 2018 06; 14(2):e33-e34.
-
Collins LE, Sager TN, Sams AG, Pennarola A, Port RG, Shahriari M, Salamone JD. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade. Pharmacol Biochem Behav. 2012 Jan; 100(3):498-505.
-
Sucheston LE, Zhao H, Yao S, Zirpoli G, Liu S, Barlow WE, Moore HC, Thomas Budd G, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Livingston RB, Albain KS, Hayes DF, Ambrosone CB. Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Res Treat. 2011 Dec; 130(3):993-1002.
-
Chen-Roetling J, Chen L, Regan RF. Minocycline attenuates iron neurotoxicity in cortical cell cultures. Biochem Biophys Res Commun. 2009 Aug 21; 386(2):322-6.
-
Avila E, Schraeder P, Belliappa A, Faro S. Pica with paradichlorobenzene mothball ingestion associated with toxic leukoencephalopathy. J Neuroimaging. 2006 Jan; 16(1):78-81.